GOSSAMER BIO, INC. (GOSS) ROA
- 2026-06-30: ROA -162.91%.
- 2026-03-31: ROA -139.95%.
- 2025-12-31: ROA -98.91%.
- 2025-09-30: ROA -74.78%.
Complete source-backed roa history.
- Available history
- 2018-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -162.91% |
|---|
| 2026-03-31 | -139.95% |
|---|
| 2025-12-31 | -98.91% |
|---|
| 2025-09-30 | -74.78% |
|---|
| 2025-06-30 | -57.59% |
|---|
| 2025-03-31 | -18.26% |
|---|
| 2024-12-31 | -17.93% |
|---|
| 2024-09-30 | -20.42% |
|---|
| 2024-06-30 | -21.65% |
|---|
| 2024-03-31 | -66.54% |
|---|
| 2023-12-31 | -57.65% |
|---|
| 2023-09-30 | -53.87% |
|---|
| 2023-06-30 | -113.78% |
|---|
| 2023-03-31 | -100.39% |
|---|
| 2022-12-31 | -84.19% |
|---|
| 2022-09-30 | -71.06% |
|---|
| 2022-06-30 | -93.87% |
|---|
| 2022-03-31 | -79.46% |
|---|
| 2021-12-31 | -68.09% |
|---|
| 2021-09-30 | -62.61% |
|---|
| 2021-06-30 | -55.46% |
|---|
| 2021-03-31 | -51.18% |
|---|
| 2020-12-31 | -45.11% |
|---|
| 2020-09-30 | -39.96% |
|---|
| 2020-06-30 | -35.86% |
|---|
| 2020-03-31 | -54.32% |
|---|
| 2019-12-31 | -42.27% |
|---|
| 2019-09-30 | -35.00% |
|---|
| 2019-06-30 | -32.59% |
|---|
| 2019-03-31 | -29.76% |
|---|
| 2018-12-31 | -61.39% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -98.91% |
|---|
| 2024-12-31 | -17.93% |
|---|
| 2023-12-31 | -57.65% |
|---|
| 2022-12-31 | -84.19% |
|---|
| 2021-12-31 | -68.09% |
|---|
| 2020-12-31 | -45.11% |
|---|
| 2019-12-31 | -42.27% |
|---|
| 2018-12-31 | -61.39% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|